IBDEI1XE ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32244,1,4,0)
 ;;=4^F18.24
 ;;^UTILITY(U,$J,358.3,32244,2)
 ;;=^5003397
 ;;^UTILITY(U,$J,358.3,32245,0)
 ;;=F70.^^141^1511^1
 ;;^UTILITY(U,$J,358.3,32245,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32245,1,3,0)
 ;;=3^Intellectual Disabilities,Mild
 ;;^UTILITY(U,$J,358.3,32245,1,4,0)
 ;;=4^F70.
 ;;^UTILITY(U,$J,358.3,32245,2)
 ;;=^5003668
 ;;^UTILITY(U,$J,358.3,32246,0)
 ;;=F71.^^141^1511^2
 ;;^UTILITY(U,$J,358.3,32246,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32246,1,3,0)
 ;;=3^Intellectual Disabilities,Moderate
 ;;^UTILITY(U,$J,358.3,32246,1,4,0)
 ;;=4^F71.
 ;;^UTILITY(U,$J,358.3,32246,2)
 ;;=^5003669
 ;;^UTILITY(U,$J,358.3,32247,0)
 ;;=F72.^^141^1511^3
 ;;^UTILITY(U,$J,358.3,32247,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32247,1,3,0)
 ;;=3^Intellectual Disabilities,Severe
 ;;^UTILITY(U,$J,358.3,32247,1,4,0)
 ;;=4^F72.
 ;;^UTILITY(U,$J,358.3,32247,2)
 ;;=^5003670
 ;;^UTILITY(U,$J,358.3,32248,0)
 ;;=F73.^^141^1511^4
 ;;^UTILITY(U,$J,358.3,32248,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32248,1,3,0)
 ;;=3^Intellectual Disabilities,Profound
 ;;^UTILITY(U,$J,358.3,32248,1,4,0)
 ;;=4^F73.
 ;;^UTILITY(U,$J,358.3,32248,2)
 ;;=^5003671
 ;;^UTILITY(U,$J,358.3,32249,0)
 ;;=F78.^^141^1511^5
 ;;^UTILITY(U,$J,358.3,32249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32249,1,3,0)
 ;;=3^Intellectual Disabilities,Oth Specified
 ;;^UTILITY(U,$J,358.3,32249,1,4,0)
 ;;=4^F78.
 ;;^UTILITY(U,$J,358.3,32249,2)
 ;;=^5003672
 ;;^UTILITY(U,$J,358.3,32250,0)
 ;;=F79.^^141^1511^6
 ;;^UTILITY(U,$J,358.3,32250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32250,1,3,0)
 ;;=3^Intellectual Disabilities,Unspec
 ;;^UTILITY(U,$J,358.3,32250,1,4,0)
 ;;=4^F79.
 ;;^UTILITY(U,$J,358.3,32250,2)
 ;;=^5003673
 ;;^UTILITY(U,$J,358.3,32251,0)
 ;;=Z00.6^^141^1512^1
 ;;^UTILITY(U,$J,358.3,32251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32251,1,3,0)
 ;;=3^Exam of Participant of Control in Clinical Research Program
 ;;^UTILITY(U,$J,358.3,32251,1,4,0)
 ;;=4^Z00.6
 ;;^UTILITY(U,$J,358.3,32251,2)
 ;;=^5062608
 ;;^UTILITY(U,$J,358.3,32252,0)
 ;;=F45.22^^141^1513^1
 ;;^UTILITY(U,$J,358.3,32252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32252,1,3,0)
 ;;=3^Body Dysmorphic Disorder
 ;;^UTILITY(U,$J,358.3,32252,1,4,0)
 ;;=4^F45.22
 ;;^UTILITY(U,$J,358.3,32252,2)
 ;;=^5003588
 ;;^UTILITY(U,$J,358.3,32253,0)
 ;;=F45.20^^141^1513^2
 ;;^UTILITY(U,$J,358.3,32253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32253,1,3,0)
 ;;=3^Hypochondiacal Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,32253,1,4,0)
 ;;=4^F45.20
 ;;^UTILITY(U,$J,358.3,32253,2)
 ;;=^5003586
 ;;^UTILITY(U,$J,358.3,32254,0)
 ;;=F45.21^^141^1513^4
 ;;^UTILITY(U,$J,358.3,32254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32254,1,3,0)
 ;;=3^Hypochondriasis
 ;;^UTILITY(U,$J,358.3,32254,1,4,0)
 ;;=4^F45.21
 ;;^UTILITY(U,$J,358.3,32254,2)
 ;;=^5003587
 ;;^UTILITY(U,$J,358.3,32255,0)
 ;;=F45.29^^141^1513^3
 ;;^UTILITY(U,$J,358.3,32255,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32255,1,3,0)
 ;;=3^Hypochondriacal Disorders NEC
 ;;^UTILITY(U,$J,358.3,32255,1,4,0)
 ;;=4^F45.29
 ;;^UTILITY(U,$J,358.3,32255,2)
 ;;=^5003589
 ;;^UTILITY(U,$J,358.3,32256,0)
 ;;=F45.8^^141^1513^9
 ;;^UTILITY(U,$J,358.3,32256,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32256,1,3,0)
 ;;=3^Somatoform Disorders NEC
 ;;^UTILITY(U,$J,358.3,32256,1,4,0)
 ;;=4^F45.8
 ;;^UTILITY(U,$J,358.3,32256,2)
 ;;=^331915
 ;;^UTILITY(U,$J,358.3,32257,0)
 ;;=F45.41^^141^1513^5
 ;;^UTILITY(U,$J,358.3,32257,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32257,1,3,0)
 ;;=3^Pain Disorder Exclusively Related to Psychological Factors
